RBC Life Sciences Press Release
U.S. and Canadian sales of RBC Life Sciences' nutritional supplements and body care products increased to $1.49 million during the first quarter of 2009 compared to $1.47 million during the first quarter of 2008. The company's MPM Medical, Inc., brand saw its wound care and pain management products sales increase 10 percent to $1.50 million during the first quarter this year compared to $1.36 million during the same quarter of 2008.
RBC Life Sciences reported company-wide net sales of $6.02 million for the quarter ended March 31, 2009, compared to net sales of $6.35 million for the same quarter last year. The company also reported a net loss of $171,000, or $0.01 per share, during the first quarter of 2009 compared to net earnings of $355,000, or $0.02 per share, in 2008.
"One of our priorities late last year was to invest in the expansion of our domestic network marketing sales base," said RBC Life Sciences President and CEO, John W. Price. "We believe this investment is bearing fruit and will reward us moving forward, although our first quarter expenses exceeded the gross profit we generated from increased sales.
Related News
-
RBC Life Sciences Reports Second Quarter Results
RBC Life Sciences Reports Second Quarter Results IRVING, Texas--(BUSINESS WIRE)--July 27, 2006--RBC Life Sciences, Inc. (OTCBB:RBCL) today reported a 16% increase in net sales to $6,203,000 in the second quarter of 2006 compared to net sales of $5,358,000 in the same period of last year. E... Read More...
